Shingles (herpes zoster) is a disease caused by the reactivation of the varicella-zoster virus (VZV) — the same virus responsible for chickenpox in childhood — in the dorsal root ganglia years later. It is characterised by painful vesicular eruptions distributed along a dermatome. The condition is not limited to the discomfort of its acute phase; it can lead to persistent nerve pain and lasting skin scarring. In 2026, early intervention and scar-prevention strategies in shingles management have seen significant advances.

Skin Involvement in Shingles

The shingles rash typically follows a unilateral, dermatomal distribution that does not cross the midline. The clinical course progresses through the following stages:

  1. Prodromal phase: Burning, stinging, and pain in the affected dermatome occur 2–4 days before the rash appears.
  2. Erythematous phase: Red, oedematous plaques emerge along the dermatome.
  3. Vesicular phase: Clusters of clear fluid-filled vesicles form on the plaques.
  4. Pustular phase: The vesicles become turbid and evolve into pustules.
  5. Crusting phase: Lesions crust over and begin to heal within 2–4 weeks.

The thoracic and lumbar dermatomes are most commonly affected; however, involvement of the trigeminal nerve — particularly its ophthalmic branch — can lead to serious complications. Shingles affecting the face can carry both functional and aesthetic consequences.

How Scarring Develops

Scarring from shingles lesions is directly related to the inflammatory damage the virus causes in the epidermis and dermis. Necrosis that reaches the deep dermal layers disrupts the collagen structure. Factors that increase the risk of scarring include:

Scar Prevention Strategies in 2026

To prevent scar formation, a multidisciplinary approach is adopted from the acute phase onward:

Early Antiviral Treatment

Antiviral therapy started within the first 72 hours of symptom onset suppresses viral replication and minimises tissue damage. Valacyclovir and famciclovir are used as standards in current treatment protocols. Early treatment both reduces the severity of the acute phase and lowers the risk of post-herpetic neuralgia.

Wound Care and Infection Control

Dermal Support During the Healing Phase

Once the acute phase has passed, silicone-based gels and sheets can be applied to minimise scar formation. These products help regulate collagen synthesis and prevent hypertrophic scarring and keloid formation. Sunscreen use is critically important to reduce the risk of hyperpigmentation in healing areas.

Advanced Dermatological Interventions

For the treatment of established shingles scars, the following methods are successfully employed in 2026:

Post-Herpetic Neuralgia and Quality of Life

Post-herpetic neuralgia — the most common complication of shingles — is severe nerve pain that can persist for months or even years after the rash heals. This condition significantly impairs patients' quality of life. Early antiviral treatment substantially reduces the likelihood of developing post-herpetic neuralgia.

Post-Shingles Care at Virtuana Clinic

At Virtuana Clinic, we provide dermatological wound care to our shingles patients during the acute phase, and meticulously apply scar prevention and treatment protocols throughout the healing period. With advanced treatment options including laser therapy, microneedling, and PRP, we aim to restore skin quality to the highest possible level for patients affected by post-shingles scarring. Please contact us for pricing information and to arrange a dermatological assessment.

This article is for informational purposes only. Please consult a qualified physician for treatment decisions.